HAVANA, Cuba, April 16  (acn) Cuba’s advances in epilepsy research will be shown on Wednesday at the  Neurocuba 2009 Congress underway in this capital, with the participation of  experts from 15 nations of Europe and the Americas.
Standing out  among its achievements is surgery in refractory epilepsy (resistant to  medication), a method that has benefited 25 Cubans with excellent results. 
With this functional surgery, which makes it possible to map the  electric activity of the brain during surgery to define the extension of  the resection, patient crises are reduced to minimum with fewer  medicines, which improves their quality of life.
The head of  Clinical Neurophysiology Services of Havana’s International Center for  Neurological Restoration (CIREN), Dr. Liliam Morales, told ACN that the  surgical procedure began to be used in the country five years ago with the  cooperation of Mexican experts, who work along with
Cubans in various  studies, among them some on electrophysiology.
Besides Cuba and Mexico,  surgery on epilepsy is carried out in Argentina and Chile, recognized by the  International League against Epilepsy.
Experts from Mexico and CIREN  continue their research work on this ailment, which consists in working on  tissue removed from patients who have undergone surgery, with the purpose of  defining the origin of the disease, which is resistant to drugs. 
Statistics confirm that epilepsy affects up to 3% of the world  population, and that almost 20% of the total of people suffering from  this chronic disease of the nervous system (seizures) does not respond  satisfactorily to pharmacological therapy, pointed out Dr. Morales. 
Wednesday’s program includes minimum access surgery, the handling and  treatment of tumors on the base of the skull, current themes and  approaches in spine surgery and the experiences of ICTUS units (to take  care of patients with acute vascular encephalic manifestations) which  
have allowed Cuba to reduce morbid-mortality due to brain-vascular  problems. 
(Expondrá Cuba  avances de investigaciones en la epilepsia)
 
No hay comentarios:
Publicar un comentario